In particular, we observed a decreasing trend of glutamine levels from samples from patients free from disease, to those with relapsed eCRC, and to mCRC.
← all excerpts
A Serum Metabolomics Classifier Derived from Elderly Patients with Metastatic Colorectal Cancer Predicts Relapse in the Adjuvant Setting.
1
—
—